T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder

European Psychiatry

Volumn 18, Issue 5, 2003, Pages 249-254

  Tot, Şenel ^a   Erdal, M Emin ^a   Yazici, Kemal ^a   Yazici, Aylin Ertekin ^a   Metin, Özmen ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

1438 G A; OCD; Polymorphism; Serotonin; T102C

Indexed keywords

ADENINE; GENE PRODUCT; GUANINE; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; RISK FACTOR; TECHNIQUE; VALIDATION PROCESS;

EID: 0041972246     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(03)00066-X     Document Type: Article

References (32)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
2. Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, et al. Evidence for association between polymorphism in the promoter and coding regions of the 5HT2A receptor gene and response to clozapine. Mol Psychiatry 1998;3:61-6.
3. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38(8):1083-152.
4. Blairy S, Massat I, Staner L, Le Bon O, Van Broeckhoven C, et al. 5-HT2A receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet 2000;96:360-4.
5. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 1997;2:403-6.
6. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwartz M, et al. The T102C polymorphism of the 5-HT2A receptor gene in fibromyalgia. Neurobiol Diseases 1999;6:433-9.
7. Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci 1986;83:4086-8.
8. Enoch MA, Kaye W, Rotondo A, Greenberg B, Murphy D, Goldman D. 5-HT2A promoter polymorphism -1438 G/A; anorexia nervosa, and obsessive compulsive disorder. Lancet 1998;351:1785-6.
9. Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE. Association between seasonal affective disorder and the 5HT2A promoter polymorphism, -1438 G/A. Mol Psychiatry 1999;4:89-92.
10. Erdal ME, Herken H, Yilmaz M, Bayazit YA. Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci 2001;188:99-101.
11. Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al. Association between obsessive compulsive-disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000;10: 205-9.
12. Goodman W, Price L, Rasmussen S, Mazure C, Delgado P, Heninger G, et al. The Yale-Brown Obsessive-Compulsive Scale: II. Validity. Arch Gen Psychiatry 1989;46:1012-6.
13. Goodman W, Rasmussen S, Mazure C, Fleischmann RL, Hill C, Heniger G, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry 1989;46: 1006-11.
14. Guy W. ECDEU Assessment manual for psychopharmacology. Rockville (MD): US Dept Health, Education and Welfare publication (ADM) 76-338. National Institute of Mental Health; 1976. p. 218-22.
15. Hartig PR, Hoyer D, Humphrey PP, Martin GR. Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci 1996;17:103-5.
16. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-4.
17. Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S. 5-HT-2A and 5-HT-2C receptor polymorphism and psychopathology in late onset Alzheimer's disease. Hum Molec Genet 1998;7:1507-9.
18. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46:157-203.
19. Huang Y, Liu X, Li T, Guo L, Sun X, Xia X, et al. Cases-control association study and transmission disequilibrium test of T102 C polymorphism in 5HT 2A and Tourette syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2001;18:11-3 [abstract].
20. Karno M, Golding JM, Sorenson SB, Burnam A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094.
21. Marshall SE, Bird TG, Hart K, Welsh KI. Unified approach to the analysis of genetic variation in serotonergic pathways. Am J Med Genet 1999;88:621-7.
22. McDougle CJ, Goodman WK, Leckman JF, Prica LH. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psych Clin North Am 1993;16:749-66.
23. McDougle CJ, Epperson CN, Price LH, Gelemtner J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A 4) and obsessive-compulsive disorder. Mol Psychiatry 1998; 3:270-3.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. Nicolini H, Cruz C, Camareno B, Orozco B, Kennedy JL, King N, et al. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-complusive disorder. Mol Psychiatry 1996;1: 461-5.
26. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
27. Rasmussen SA, Tsuang MT. DSM-4 obsessive compulsive disorder: clinical characteristics and family history. Am J Psychiatry 1986; 143: 317-22.
28. Sparkes RS, Lan N, Klisak I, Mohandas T, Diep A, Kojis T, et al. Assignment of a serotonin 5HT-2 receptor gene (HTR2) to human chromosome 13q14-q21 and mouse chromosome 14. Genomics 1991;9:461-5.
29. Spurlock G, Heils A, Holmans P, Williams J, D'Souza UM, Cardno A, et al. A family based association study of T1202C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphism in the promoter. Mol Psychiatry 1998;3:42-9.
30. Stein DJ. Advances in the neurobiology of obsessive-compulsive disorder. Implications for conceptualizing putative obsessive-compulsive and spectrum disorders. Psychiatr Clin North Am 2000;23(3): 545-62.
31. Tek C, Ulug B, Rezaki BG, Tanriverdi N, Mercan S, Demir B, et al. Yale-Brown obsessive compulsive scale and US National Institute of Mental Health global obsessive compulsive scale in Turkish: reliability and validity. Acta Psychiatr Scand 1995;91:410-3.
32. Trimble MR. Biological psychiatry. 2nd ed. Chichester: John Wiley & Sons; 1996.